comparemela.com

Latest Breaking News On - Risk factors in company - Page 1 : comparemela.com

DiagnaMed's BRAIN AGE® Brain Health AI Platform Targeting

DiagnaMed's BRAIN AGE® Brain Health AI Platform Targeting
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Montreal
Quebec
Toronto
Ontario
America
Canadian
Fabio-chianelli
Fleck-jessica
Kounios-john
Zhang-fengqing

DiagnaMed Announces LIFE Offering of up to $650,000

DiagnaMed Announces LIFE Offering of up to $650,000
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
Toronto
Ontario
Canada
Canadian
America
Fabio-chianelli
Financial-inc
Canadian-securities-exchange
Brain-health-ai-platform
Drexel-university
Risk-factors-in-company

PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug Application for Ketamine

PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug Application for Ketamine
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Toronto
Ontario
Canada
Canadian
Fabio-chianelli
Health-canada
Pharmather-holdings-ltd
Risk-factors-in-company
Sairiyo-therapeutics-inc
Drug-administration
Neither-the-canadian-securities-exchange
Company-on

OLAPLEX Reports First Quarter 2024 Results

OLAPLEX Reports First Quarter 2024 Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
Lisa-bobroff
Amanda-baldwin
Patrick-flaherty
Neither-the-company
Olaplex-holdings-inc
Risk-factors-in-company
Global-communications-consumer-engagement
Advent-international
Nasdaq
Exchange-commission
Company-on

PharmaTher's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

PharmaTher's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Toronto
Ontario
Australia
Japan
Australian
Canadian
Fabio-chianelli
Company-or-pharmather
Regulation-services-provider
Pharmather-holdings-ltd

vimarsana © 2020. All Rights Reserved.